APH 1902
Alternative Names: APH-1902Latest Information Update: 09 Dec 2021
At a glance
- Originator Aphios Corporation
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Liver-kidney transplant rejection
Most Recent Events
- 25 Nov 2021 Early research in Liver-kidney transplant rejection (Prevention) in USA (unspecified route) prior to November 2021 (Aphios Corporation pipeline, November 2021)
- 25 Nov 2021 Preclinical trials in Liver-kidney transplant rejection (Prevention) in USA (unspecified route) prior to November 2021 (Aphios Corporation pipeline, November 2021)